Safety Profile of Crizanlizumab 5.0 Mg/Kg in Sickle Cell Disease: Pooled Data from Clinical Trials

被引：1
|
作者：
Kutlar, Abdullah [1 ]
Joshi, Vikas [2 ]
Brueckner, Andreas [3 ]
Kanter, Julie [4 ]
Liles, Darla K. [5 ]
Lincy, Jeremie [3 ]
Manjare, Rahul [2 ]
Adomakoh, Yvonne Dei [6 ]
Heeney, Matthew M. [7 ]
de Montalembert, Mariane [8 ]
Keefe, Deborah [9 ]
Marfo, Kwaku [3 ]
Ataga, Kenneth I. [10 ]
机构：
[1] Med Coll Georgia, Augusta, GA USA
[2] Novartis Healthcare Private Ltd, Hyderabad, India
[3] Novartis Pharma AG, Basel, Switzerland
[4] Univ Alabama Birmingham, Birmingham, AL USA
[5] East Carolina Univ, Brody Sch Med, Greenville, NC USA
[6] Univ Ghana, Korle Bu Teaching Hosp, Med Sch, Accra, Ghana
[7] Boston Childrens Hosp, 300 Longwood Ave, Boston, MA USA
[8] Univ Paris Cite, Necker Enfants Malades Hosp, Assistance Publ Hop Paris AP HP, Paris, France
[9] Novartis Pharmaceut, E Hanover, NJ USA
[10] Univ Tennessee, Hlth Sci Ctr, Memphis, TN USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-188639
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：5
相关论文
共 50 条
  • [1] Crizanlizumab 5.0 Mg/Kg Exhibits a Favorable Safety Profile in Patients with Sickle Cell Disease: Pooled Data from Two Phase II Studies
    Kanter, Julie
    Liles, Darla K.
    Smith-Whitley, Kim
    Brown, Clark
    Kutlar, Abdullah
    Elliott, Brian
    Shah, Amit
    Lincy, Jeremie
    Poggio, Susan
    Ataga, Kenneth I.
    BLOOD, 2019, 134
  • [2] Crizanlizumab 5.0 Mg/Kg Increased the Time to First on-Treatment Sickle Cell Pain Crisis: A Subgroup Analysis of the Phase II Sustain Study
    Kanter, Julie
    Kutlar, Abdullah
    Liles, Darla
    Cancado, Rodolfo
    Bruederle, Andreas
    Shi, Michael
    Zhu, Zewen
    Ataga, Kenneth I.
    BLOOD, 2017, 130
  • [3] Pharmacokinetics, pharmacodynamics, safety, and efficacy of crizanlizumab in patients with sickle cell disease
    Kanter, Julie
    Brown, R. Clark
    Norris, Cynthia
    Nair, Santosh M.
    Kutlar, Abdullah
    Manwani, Deepa
    Shah, Nirmish
    Tanaka, Chiaki
    Bodla, Shankaranand
    Sanchez-Olle, Gessami
    Albers, Urs
    Liles, Darla
    BLOOD ADVANCES, 2023, 7 (06) : 943 - 952
  • [4] Safety of insulin lispro: Pooled data from clinical trials
    Glazer, NB
    Zalani, S
    Anderson, JH
    Bastyr, ED
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1999, 56 (06) : 542 - 547
  • [5] Eliglustat safety profile based on a pooled analysis of data from four trials in Gaucher disease type I
    Ross, Leorah
    Peterschmitt, Judith
    Puga, Ana C.
    Cox, Gerald F.
    Marulkar, Sachin
    Angell, Jennifer
    Gaemers, Bas
    Mankoski, Raymond
    MOLECULAR GENETICS AND METABOLISM, 2014, 111 (02) : S90 - S90
  • [6] Efficacy, Safety, and Biomarker Analysis of 5 Mg and 7.5 Mg Doses of Crizanlizumab in Patients with Sickle Cell Disease: Primary Analyses from the Phase III STAND Study
    Abboud, Miguel R.
    Cancado, Rodolfo D.
    De Montalembert, Mariane
    Smith, Wally R.
    Rimawi, Hala
    Voskaridou, Ersi
    Guvenc, Birol
    Keefe, Deborah
    Grosch, Kai
    Nassin, Michele L.
    Watson, Jimmy
    Yssel, Justin
    Reshetnyak, Evgeniya
    Adomakoh, Yvonne Dei
    BLOOD, 2023, 142
  • [7] Profile of crizanlizumab and its potential in the prevention of pain crises in sickle cell disease: evidence to date
    Riley, Tanya R.
    Riley, Treavor T.
    JOURNAL OF BLOOD MEDICINE, 2019, 10 : 307 - 311
  • [8] Clinical Profile of Sickle Cell Disease in Orissa
    Kar B.C.
    Devi S.
    The Indian Journal of Pediatrics, 1997, 64 (1) : 73 - 77
  • [9] Safety profile of belzutifan monotherapy in patients with renal cell carcinoma: A pooled analysis of 4 clinical trials
    Choueiri, Toni K.
    Ghatalia, Pooja
    de Velasco, Guillermo
    Albiges, Laurence
    Burotto, Mauricio
    Suarez, Cristina
    Brugarolas, James
    Iacovelli, Roberto
    Jalkanen, Katriina
    Lam, Elaine T.
    Srinivasan, Ramaprasad
    Merchan, Jaime
    Agarwal, Neeraj
    Iversen, Ane B.
    Rini, Brian
    Bauer, Todd M.
    Gurney, Howard
    Iliopoulos, Othon
    Lin, Jianxin
    Starkopf, Liis
    Donica, Margarita
    Gumieniak, Olga
    Vickery, Donna
    Liu, Yanfang
    Perini, Rodolfo F.
    Powles, Thomas
    Jonasch, Eric
    ONCOLOGIST, 2024, 29
  • [10] Pooled Analysis of Safety Data from Clinical Trials of Orelabrutinib Monotherapy in Hematologic Malignancies
    Song, Yuqin
    Xu, Wei
    Song, Yongping
    Liu, Lihong
    Lin, Song
    Li, Zhiming
    Liu, Ting
    Yi, Shuhua
    Zhou, Daobin
    Zhang, Mingzhi
    Hu, Yu
    Jin, Jie
    Zhu, Huaqiang
    Lu, Zhengguang
    Zhao, Renbin
    Xu, Zhixin
    Zhu, Jun
    BLOOD, 2020, 136
12345